GDF - Medical Technology Development

Abstract

Guidance for Development of the Force - Medical Technology Development provides funds for promising candidate solutions that are selected for initial safety and effectiveness testing in animal studies and/or small-scale human clinical trials regulated by the US Food and Drug Administration prior to licensing for human use. Research in this PE is designed to address the following: areas of interest to the Secretary of Defense regarding Wounded Warriors, capabilities identified through the Joint Capabilities Integration and Development System, and sustainment of priority investments in science, technology, research and development as stated in the Quadrennial Defense Review. Program development and execution is peer reviewed and fully coordinated with all of the Military Services, appropriate Defense Agencies or Activities and other Federal Agencies, to include the Department of Veterans Affairs, the Department of Health and Human Services, and the Department of Homeland Security. This coordination occurs through the planning and execution activities of the Joint Program Committees (JPCs), established for the Defense Health Program (DHP) Research Development Test and Evaluation (RDT&E) funding. Research supported by this PE includes(JPC-1): medical simulation, health informatics, (JPC-2): wound infection prevention and management, antimicrobial countermeasures, diagnostic systems for infectious diseases, (JPC-5): injury prevention and reduction, psychological health and resilience, physiological health, environmental health and protection, (JPC-6): hemorrhage (bleeding) and resuscitation, neurotrauma (diagnosis and treatment of brain injury), traumatic tissue injury, forward surgical intensive critical care, joint en route care, military medical photonics, and (JPC-8): rehabilitation of neuro-musculoskeletal injuries, pain management, regenerative medicine, and sensory system traumatic injury, restoration and rehabilitation. As research efforts mature, the most promising will transition to advanced concept development funding, PE 0604110. For knowledge products, successful findings will transition into clinical practice guidelines.

Open PDF

Document Details

Document Type
Project
Publication Date
Oct 01, 2016
Source ID
373A_0603115HP_2_0130_PB_2016

Tags

Fields of Study

  • Medicine

Readers

  • Military Science and Technology Research and Modernization.
  • Neurotrauma and Rehabilitation Medicine.
  • Trauma or Military Medicine

Related Documents